ZG-0588

N/A

Report date: 2026/04/08 15:32:14
NME

Base Information

Drug NameZG-0588
Drug Alias NameZG-0588
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaDiscontinued
Originator CompaniesSuzhou Zelgen Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuzhou Zelgen Biopharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A